Regulatory T (Treg) cells play a central role in regulating peripheral immune tolerance and preventing autoimmunity. Despite the extensive studies on the development of Treg cells, the molecular mechanisms that maintain the population of committed Treg cells remain poorly understood. We show here that Treg-conditional ablation of the kinase TAK1 reduced the number of Treg cells in the peripheral lymphoid organs, causing abnormal activation of conventional T cells and autoimmune symptoms. Using an inducible gene knockout approach, we further demonstrate that TAK1 is crucial for the survival of Treg cells. Expression of a constitutively active IkB kinase partially restored the level of Treg cells in the TAK1Treg-KO mice. These results suggest a crucial role for TAK1 for maintaining the survival of committed Treg cells under physiological conditions.
INTRODUCTION
Foxp3 expressing regulatory T (Treg) cells play a central role in maintaining peripheral immune tolerance and, thereby, preventing autoimmunity and chronic inflammations. 1, 2 Treg cells suppress the activation of conventional T cells and other immune cells via both cell-cell contact and the immunosuppressive action of secreted cytokines, such as transforming growth factor-b (TGF-b), IL-10, and IL-35. 1, 3, 4 Most Treg cells are developed in the thymus, although Treg cells can also be inducibly produced in the periphery from conventional T cells in the presence of TGF-b and retinoic acid. 5, 6 Both the development and immunosuppressive function of Treg cells are critically dependent on the transcription factor Foxp3 and its regulatory factors. 7 Genetic deficiencies in these core regulators of Treg cells are associated with perturbed T-cell homeostasis and severe autoimmunity.
The NF-kB signaling pathway is important for the development of Treg cells. 8, 9 Diverse immune stimuli induce the canonical NF-kB pathway through activation of its upstream kinase, the IkB kinase (IKK). Activation of IKK/NF-kB by the T-cell receptor (TCR) involves a signaling complex that is composed of the scaffold protein CARMA1, the adaptor BCL10, and the paracaspase MALT1. 10, 11 The signaling function of this so-called CBM complex requires a ubiquitin-conjugating enzyme, UBC13, which mediates lysine 63 (K63) ubiquitination of the IKK regulatory subunit NEMO and the IKK-activating kinase TAK1 required for catalytic activation of the TAK1-IKK signaling axis. 12 Genetic deficiencies in the CBM component or the downstream signaling factors, TAK1, IKK, and NF-kB, severely attenuates the thymic development of Treg cells. [13] [14] [15] [16] [17] [18] [19] [20] [21] In addition, conditional UBC13 knockout (KO) studies revealed that the UBC13-IKK signaling axis regulates the function of Treg cells and prevent their conversion into inflammatory T cells. 22 In addition to mediating IKK activation, TAK1 targets the activation of MAP kinases, including ERK, p38, and JNK. [23] [24] [25] TAK1 transduces signals from multiple immune receptors, including the toll-like receptors (TLRs), TCR, B-cell receptor (BCR), and TNF receptor (TNFR) superfamily members. [24] [25] [26] TAK1 has also been implicated in the regulation of survival signals stimulated by common gamma chain cytokines. thymocyte development. 14, 27, 28 Ablation of TAK1 in immature thymocytes, using LCK-Cre or CD4-Cre, severely reduces the generation of CD4 and CD8 single-positive thymocytes as well as Treg cells in the thymus. 14, 27, 28 However, the role of TAK1 in mediating the survival and homeostasis of committed Treg cells has remained unknown. In the present study, we addressed this question by generating Treg cell-conditional TAK1 KO mice using the Foxp3-Cre approach. We found that TAK1 is indispensable for maintaining the peripheral population of Treg cells.
MATERIALS AND METHODS

Mice
Mice with loxP-flanked TAK1 allele (TAK1-flox mice) were provided by Dr. Shizuo Akira (Osaka University).
14,24 Foxp3-EGFP-hCre mice (Jackson Lab) carry a bacterial artificial chromosome transgene that expresses enhanced green fluorescence protein (EGFP) and a humanized Cre under the control of mouse Foxp3 promoter. These mice were backcrossed for nine generations onto the C57BL/6 background and then crossed with TAK1-flox mice to produce age-matched TAK1 Cell preparation and flow cytometric analysis Mononuclear cells were isolated form the spleen and intestinal lamina propria as previously described. 22 Flow cytometric analyses were performed using a FACSCalibur (BD). For intracellular cytokine staining, cells were stimulated with 50 ng/ml PMA (Sigma-Aldrich) plus 750 ng/ml ionomycin (Calbiochem) for 4-6 h in the presence of 10 mg/ml monensin (eBioscience), and the fixed cells were incubated with the indicated antibodies and subjected to flow cytometry. Antibodies were described previously. 22, 30 In vitro Treg differentiation and TAK1 deletion CD4 1 CD25 -naïve T cells (.98% purity), isolated from TAK1 1/1 Cre ERT2 or TAK1 fl/fl Cre ERT2 mice, were stimulated under Treg skewing conditions (5 mg/ml anti-IL-4, 5 mg/ml anti-IFN-c and 2.5 ng/ml TGF-b (R&D System, 240-B) plus 10 ng/ml IL-2 (R&D System, 402-ML)). After 3 days, the cells were treated with1 mM tamoxifen (Sigma-Aldrich) for 24 h to induce TAK1 gene deletion. After removing tamoxifen, in vitro generated Treg cells were resuspended in fresh media and used for the indicated experiments.
Apoptosis assay
Apoptosis was detected using a commercial kit (BD Pharmingen) based on Annexin V binding to apoptotic cells and propidium iodide (PI) staining of late-stage apoptotic cells and necrotic cells. In brief, cells were resuspended in 1 3 binding buffer containing fluorescein isothiocyanate-conjugated Annexin V (Annexin V-FITC) and PI. After incubation for 15 min at room temperature in the dark, the cell suspension was diluted with 1x binding buffer and subjected to cytometry analyses.
Histology
Organs were removed from sacrificed mice, fixed in 10% neutral buffered formalin, embedded in paraffin and sectioned for hematoxylin and eosin staining.
Statistical analysis
Prism software was used for two-tail unpaired t-tests. P-values of less than 0.05 or 0.01 were considered significant and very significant, respectively.
RESULTS
Ablation of TAK1 in Treg cells causes autoimmune symptoms
To examine the function of TAK1 in Treg cells, we generated Treg-conditional TAK1 KO mice by crossing the TAK1-floxed mice 14 with Foxp3-Cre mice. We used the resulting TAK1 (Figure 1a ). TAK1 Treg-KO mice were born at the expected Mendelian ratios and did not have obvious abnormality in growth and survival. However, these mutant mice had profoundly enlarged spleen, mesenteric lymph nodes (LNs), and peripheral LNs, an autoimmune phenotype often associated with perturbed immune cell homeostasis ( Figure 1b) . Indeed, the peripheral lymphoid organs of the TAK1 Treg-KO mice also had increased cellularity ( Figure 1c ). On the other hand, histology analyses revealed that the TAK1 Treg-KO mice only displayed mild tissue inflammation at older ages, mostly seen in the kidney (Figure 1d ). These results suggest that Treg-specific ablation of TAK1 causes certain aspects of autoimmunity but does not lead to severe inflammatory disorders.
Abnormal activation of conventional T cells in TAK1
Treg-KO mice A well-defined function of Treg cells is to maintain immune homeostasis and prevent T-cell activation by self-antigens. Since Treg has an important role in regulating immune homeostasis in the intestine, we examined the effect of Treg cell-specific TAK1 ablation on the frequency of T cells in the lamina propria of the small and large intestines. The TAK1 Treg-KO mice had a moderate reduction in the frequency of CD4
1 and CD8 1 T cells in the lamina propria of the small intestine ( Figure 2f ). However, the CD4 1 T cell population of TAK1 Treg-KO mice had a much greater frequency of Th1 cells in the lamina propria of both the small and large intestines. The large intestine of TAK1
Treg-KO mice also had a moderate increase in the frequency of Th17 cells, although this result was not statistically significant ( Figure 2g ). Thus, Treg-specific ablation of TAK1 perturbed the homeostasis of TAK1-sufficient conventional T cells, which suggests that TAK1 may regulate the survival or immunosuppressive function of Treg cells.
TAK1 is required for the maintenance of Treg cells
To assess the mechanism by which TAK1 regulating Treg function, we examined the expression of Treg-signature molecules on WT and TAK1-deficient Treg cells. The Treg cells derived from the TAK1 Treg-KO mice had competent expression of several surface molecules analyzed (Figure 3a) . In fact, the expression of some of these molecules, including CD44, CD103, ICOS, and GITR, was substantially enhanced in TAK1-deficient Treg cells (Figure 3a) . It has been suggested that Treg cells expressing high levels of these molecules represent an effector/memory Treg population that is often seen at site of immune response or inflammation. 
Compared with WT-R26
YFP mice, TAK1
Treg-KO R26 YFP mice had a strikingly lower frequency of YFP 1 population of Treg cells even when they were young (Figure 3c and d (Figure 3f) . Importantly, the GFP -Treg cell population from the TAK1 Treg-KO mice expressed a substantial level of TAK1, suggesting leakage in TAK1 expression. These findings explained why the autoimmune symptoms of the TAK1 Treg-KO mice were not quite serious.
TAK1 ablation causes Treg cell apoptosis
The great reduction in YFP 1 Treg cells in the TAK1 To further confirm the essential role for TAK1 in mediating Treg cell survival, we employed Cre ERT2 mice, in which the Cre activity could be induced by tamoxifen. We generated Treg cells in vitro using naïve CD4 1 T cells derived from WT or TAK1 fl/fl Cre ERT2 mice (Figure 4c ). We then incubated the Treg cells with tamoxifen, which led to efficient ablation of TAK1 (Figure 4d ). The loss of TAK1 was in turn associated with impaired NF-kB signaling detected based the phosphorylation of NF-kB p65 (Figure 4e ). While tamoxifen had little effect on the survival of the WT Treg cells, tamoxifen induced massive cell death in the TAK1 fl/fl Cre ERT2 Treg cells (Figure 4e and f) . Taken together, these results suggest that TAK1 is a critical factor that mediates Treg cell survival.
IKK partially mediates the function of TAK1 in Treg cell homeostasis The major downstream signaling pathways of TAK1 include those leading to the activation of IKK and two MAP kinases, p38 and JNK. [23] [24] [25] To determine the role of IKK signaling in TAK1-mediated Treg survival, we restored IKK signaling in Cre ERT2 and TAK1 fl/fl Cre ERT2 mice were stimulated with coated anti-CD3 (5 mg/ml) and anti-CD28 (1 mg/ml) antibodies plus TGF-b (2.5 ng/ml) and IL-2 (10 ng/ml). After 3 days, Foxp3 expression was detected by flow cytometry. (d, e) Treg cells, described in c, were treated with tamoxifen for 24 h. After removing the tamoxifen, cells were subjected to immunoblot (d) or flow cytometric analyses of p65 phosphorylation under unstimulated or stimulated (anti-CD3 plus anti-CD28 for 15 min by a crosslinking method) conditions (e). (f, g) Treg cells, described in c, were treated with either medium control or tamoxifen for 24 h and then restimulated in fresh media with plate-bound anti-CD3 and anti-CD28 antibodies for 24 h. Apoptotic cells were detected by flow cytometry based on Annexin V and PI staining (f), and the frequency of viable cells (annexinV -PI -) was presented as mean 6 SE values of the indicated numbers of mice (each circle represents a mouse) (g). *P , 0.05 (two-tailed unpaired t-test). Data are representative of three independent experiments with four mice per group. 
DISCUSSION
The data presented in this paper demonstrate a crucial role for TAK1 in maintaining the peripheral population of Treg cells. Loss of TAK1 in committed Treg cells causes Treg cell apoptosis. As a result, the TAK1 Treg-KO mice had reduced frequency of Treg cells, coupled with aberrant activation of conventional T cells and autoimmune symptoms. The mutant animals had enlargement of spleen and LNs and increased cellularity in these peripheral lymphoid organs. In addition, the kidneys of the TAK1 Treg-KO mice had hemorrhage, although the other organs did not show obvious inflammation.
Prior studies suggest that TAK1 is crucial for the development of Treg cells in the thymus, 14, 27, 28 but the role of TAK1 in regulating committed Treg cells has remained unclear. Using the Foxp3-Cre system, our current work revealed an indispensable function of TAK1 in maintaining the Treg cell population. This conclusion was further confirmed by experiments using an inducible Cre (Cre ERT2 ) system, which showed that ablation of TAK1 in vitro also causes Treg cell apoptosis. TAK1 is a kinase that mediates the activation of IKK and two MAP kinases, p38 and JNK. Our data suggest that IKK is partially involved in the function of TAK1 in Treg cells, since the expression of an active form of IKK2 (IKK2CA) significantly, although not completely, rescued the survival of TAK1-deficient Treg cells. TAK1-induced MAP kinases are known to mediate survival of conventional T cells. 33 Transgenic expression of constitutive IKK2 in T cell-conditional TAK1 KO mice fails to rescue the survival of thymocytes and peripheral conventional T cells, although it rescues the Foxp3 expression in the TAK1-deficient T cells. 20 It is thus possible that the survival function of TAK1 in committed Treg cells requires both the IKK/NF-kB pathway and the MAP kinase pathways.
We have previously shown that ablation of the ubiquitinconjugating enzyme UBC13 using Foxp3-Cre has little effect on the homeostasis of Treg cells, although UBC13 is essential for maintaining the immunosuppressive function of Treg cells under lymphopenic and inflammatory conditions. 22 Like TAK1, UBC13 mediates TCR-stimulated activation of IKK as well as JNK and p38. [34] [35] [36] It is thus somewhat surprising that these two molecules have distinct roles in regulating Treg cell survival. Since UBC13 functions more upstream of TAK1, it is possible that TAK1 integrates signals from different immune receptors, whereas UBC13 may respond to more selective signals such as the TCR signal. In this regard, a prior study suggests that TAK1 mediates the survival signals from common gamma chain family of cytokine receptors in conventional T cells. 27 Despite the crucial role of TAK1 in mediating Treg survival, the overall autoimmune phenotype of the TAK1 Treg-KO mice was not particularly severe. They had splenomegaly and lymphadenopathy with increased cellularity in the peripheral lymphoid organs. However, these mutant animals did not show substantial inflammations in various organs and tissues examined, except the kidney. Using a Treg-reporter system, we found that the TAK1 Treg-KO mice had expansion of Treg cells that had escaped the Cre-mediated TAK1 ablation. Such a Tak1 regulates Treg cell survivalcompensatory response was also observed in TAK1 ablation in conventional T cells using CD4-Cre. 27 In summary, our study demonstrates that TAK1 is crucial for peripheral maintenance of Treg cells in addition to its role in regulating Treg cell development in the thymus.
